2012
DOI: 10.1093/brain/aws024
|View full text |Cite
|
Sign up to set email alerts
|

Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease

Abstract: Huntington's disease is an inherited neurodegenerative disease that causes motor, cognitive and psychiatric impairment, including an early decline in ability to recognize emotional states in others. The pathophysiology underlying the earliest manifestations of the disease is not fully understood; the objective of our study was to clarify this. We used functional magnetic resonance imaging to investigate changes in brain mechanisms of emotion recognition in pre-manifest carriers of the abnormal Huntington's dis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
73
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 84 publications
(81 citation statements)
references
References 58 publications
7
73
0
1
Order By: Relevance
“…HD is an autosomal-dominant inherited disease and is caused by an expansion of the CAG trinucleotide repeat in exon 1 of the Huntingtin (Htt) gene, resulting in the expansion of a polyglutamine tract in the protein (Montoya et al, 2006;Novak et al, 2012). MR imaging has identified marked gaps in the cerebral blood flow in HD.…”
Section: Huntington Diseasementioning
confidence: 99%
“…HD is an autosomal-dominant inherited disease and is caused by an expansion of the CAG trinucleotide repeat in exon 1 of the Huntingtin (Htt) gene, resulting in the expansion of a polyglutamine tract in the protein (Montoya et al, 2006;Novak et al, 2012). MR imaging has identified marked gaps in the cerebral blood flow in HD.…”
Section: Huntington Diseasementioning
confidence: 99%
“…This additional recruitment of superior and middle frontal gyrus was positively associated with CAG repeat numbers, representing another measure of disease load, rendering the interpretation of frontal recruitment as compensatory more credible (80). Interestingly, medial frontal areas also form part of the DMN, mirroring the above-mentioned interpretation of sustained performance through supporting task-negative regions by Wolf and colleagues (77).…”
Section: Further Cognitive Domains and Compensatory Brain Activity Inmentioning
confidence: 99%
“…HD affects the whole brain, but the most prominent early effect is characterized by a loss of small to medium spiny neurons in the caudate and putamen (Vonsattel & DiFiglia, 1998). However, other neuropathology (e.g., corticostriatal gray-matter atrophy, white-matter volume loss) and subtle signs of the disease, including cognitive changes, are seen during the prodromal HD (prHD) phase, decades prior to the diagnosis of manifest HD (Duff et al, 2010; Harrington, Smith, Zhang, Carlozzi, & Paulsen, 2012; Nopoulos et al, 2010; Novak et al, 2012; Paulsen et al, 2006; Paulsen et al, 2008; Paulsen et al, 2001; Rosas et al, 2005). In conjunction with efforts to identify efficacious treatments to slow disease progression, there has been a concerted effort to identify neuroimaging biomarkers of early brain changes that could serve as outcomes in primary prevention trials of individuals in the prHD phase, when treatments are more likely to succeed.…”
Section: Introductionmentioning
confidence: 99%
“…Yet the brain mechanisms that govern different facets of cognitive decline in prHD are not well understood. Emerging functional imaging studies report different disease-related patterns of activation during working memory (Wolf et al, 2008; Wolf, Vasic, Schonfeldt-Lecuona, Landwehrmeyer, & Ecker, 2007), attention (Wolf et al, 2012), interference (Reading et al, 2004), temporal processing (Paulsen et al, 2004; Zimbelman et al, 2007), set shifting (Gray et al, 2013), and implicit emotion processing (Novak et al, 2012), typically without deficits in task performance. Some studies report changes in brain functioning in individuals far from a diagnosis (Paulsen et al, 2004; Wolf et al, 2007; Zimbelman et al, 2007), despite the absence of cognitive decline and/or striatal atrophy.…”
Section: Introductionmentioning
confidence: 99%